NYSE: RMD
Resmed Inc Stock Ownership - Who owns Resmed?

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael J. FarrellChief Executive Officer2025-07-078,009$101.64
$814.03kBuy
Michael J. FarrellChief Executive Officer2025-07-078,009$256.72
$2.06MSell
Peter C. FarrellDirector2025-07-02945$255.49
$241.44kSell
Michael J. RiderGlobal General Counsel2025-07-0166$256.99
$16.96kSell
Brett SandercockChief Financial Officer2025-07-01917$101.64
$93.20kBuy
Brett SandercockChief Financial Officer2025-07-013,883$256.99
$997.89kSell
Brett SandercockChief Financial Officer2025-07-011,966$101.64
$199.82kBuy
Michael J. FarrellChief Executive Officer2025-06-098,009$251.21
$2.01MSell
Michael J. FarrellChief Executive Officer2025-06-098,009$101.64
$814.03kBuy
Peter C. FarrellDirector2025-06-042,000$247.32
$494.64kSell

1 of 10

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc12.61%18,493,702$4.77BInstitution
Blackrock Inc8.66%12,692,014$3.28BInstitution
State Street Corp4.47%6,551,404$1.69BInstitution
Bank Of New York Mellon Corp3.55%5,204,217$1.34BInstitution
Morgan Stanley2.82%4,139,611$1.07BInstitution
Geode Capital Management LLC2.81%4,116,428$1.06BInstitution
Invesco Ltd1.56%2,294,031$592.02MInstitution
Northern Trust Corp1.19%1,744,541$450.21MInstitution
Christopher G. Roberts1.16%1,700,337$438.81MInsider
Michael A. 1. Quinn0.87%1,277,650$329.72MInsider

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD63.37%4.23%Net SellingNet Selling
ALC49.96%0.00%
BDX89.03%0.66%Net SellingNet Selling
WST95.69%3.76%Net Buying
COO98.52%1.19%Net Selling

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 63.37% institutional shareholders, 4.23% Resmed insiders, and 32.39% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.16% of the company. Christopher G. Roberts's Resmed shares are currently valued at $432.57M.

If you're new to stock investing, here's how to buy Resmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.